Core Viewpoint - InnoCare Pharma (02577.HK) announced that its chairman and controlling shareholder, Dr. Weiwei Luo, has issued a lock-up commitment, agreeing not to sell approximately 155 million shares of the company for 12 months starting from January 22, 2026, reflecting confidence in the company's future development and long-term investment value [1]. Group 1 - Dr. Luo's lock-up commitment includes 77.35277 million shares of unlisted domestic shares and 77.35277 million H-shares [1]. - The commitment is based on Dr. Luo's recognition of the company's potential in the context of global energy structure transformation and revolutionary improvements in energy efficiency [1]. - The company believes that GaN power chips, with their high frequency, efficiency, and power density, will play a disruptive role in key sectors such as new energy vehicles, data centers, industrial energy storage, humanoid robots, and consumer electronics, indicating a broad market outlook [1].
英诺赛科(02577.HK)：董事长Luo博士自愿承诺禁售1.55亿股 彰显长期发展信心